Researchers Use Visikol® Histo-M™ to Study Diabetes
Diabetes affects approximately 37.3 million people and can lead to both short-term and long-term consequences. The most common type [...]
9 Important Things to Consider for Immunofluorescent Labeling
Immunofluorescent labeling is a very useful tool in both in vitro and in vivo studies, and there are many [...]
The Race to Finding a Cure for Alzheimer’s
Notoriously known for its symptoms of mental decline, Alzheimer’s Disease (AD) is a common disease that is mainly found [...]
Visikol CEO To Speak at 3rd International Conference Series on 3R’s Research & Progress
Visikol CEO Michael Johnson, Ph.D., will be speaking at The 3rd International Conference Series on 3R's Research & [...]
Long-Term Hepatitis B Infection in a Scalable Hepatic Co-Culture System
Hepatitis B virus causes chronic infections in 250 million people worldwide. HBV cccDNA is responsible for the cause of [...]
Researchers Use Visikol® HISTO™ to Study Glaucoma
Full retina image Glaucoma afflicts approximately 60 million people worldwide, with a projected growth of [...]
Visikol – The Leading Provider of Multiplex Tissue Imaging Services
Visikol started providing researchers with advanced tissue imaging services over six years ago and over this period of time [...]
Standard BioTools Announces Collaboration Agreement With Visikol to Offer Multiplex Imaging Mass Cytometry Services
SOUTH SAN FRANCISCO, Calif., October 11, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose [...]
Download Our New Multiplex Tissue Imaging eBook
Download our Multiplex Tissue Imaging eBook Today! With the recent advances in the field of tumor immunology and cancer immunotherapy, [...]
Creating ImageJ Macros with User Inputs
ImageJ is a wonderful, free program that has become somewhat of a standard for image processing and quantification. The [...]